2019
DOI: 10.3389/fnins.2019.00163
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Potential of Extracellular Vesicles for the Treatment of Nerve Disorders

Abstract: The use of extracellular vesicles (EVs) as cell free therapy is a promising approach to stimulate tissue regeneration including that of the nervous system. EVs transfer bioactive proteins and lipids, RNA and microRNAs, which play a relevant role in EV-mediated intercellular communication. The immunomodulatory, anti-inflammatory, and neuroprotective effects of mesenchymal stem cells-derived EVs have been well studied, knowledge of this paracrine mechanism and the availability of these cells, positions mesenchym… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
48
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 74 publications
(49 citation statements)
references
References 70 publications
1
48
0
Order By: Relevance
“…In line with these findings, several studies demonstrated a beneficial impact on nerve regeneration after introducing ADSCs [26][27][28]. Of note, there is increasing evidence that the regenerative effect of stem cells is also mediated via extracellular vesicles (EVs) [29][30][31][32][33]. EVs are defined as heterogenous entities of phospholipid bilayer delimited vesicles without any means of replication that differ in their biogenesis, composition and size [34][35][36].…”
Section: Introductionmentioning
confidence: 83%
See 1 more Smart Citation
“…In line with these findings, several studies demonstrated a beneficial impact on nerve regeneration after introducing ADSCs [26][27][28]. Of note, there is increasing evidence that the regenerative effect of stem cells is also mediated via extracellular vesicles (EVs) [29][30][31][32][33]. EVs are defined as heterogenous entities of phospholipid bilayer delimited vesicles without any means of replication that differ in their biogenesis, composition and size [34][35][36].…”
Section: Introductionmentioning
confidence: 83%
“…In addition, EVs may release their content into the extracellular space or act as antigen presenters [35,40]. Hence, ADSC derived EVs (ADSC-EVs) could offer a therapeutic alternative for regenerative approaches by avoiding the risk of cell-based therapies [29][30][31]43].…”
Section: Introductionmentioning
confidence: 99%
“…Experimental approaches for the treatment of SCI have been evolving and currently include a variety of approaches with a significant prevalence of genetic [43][44][45] and cellular therapies. Cells of adult organism, embryonic cells, and induced pluripotent stem cells have been used in multiple studies with variable effects [46][47][48], as has the application of extracellular vesicles as a cell-free therapy [49]. In the context of safety and practical capacity of translation into the clinic, MSCs appear to be the most promising therapy at the current time [50].…”
Section: Discussionmentioning
confidence: 99%
“…This means that EVs have better advantages in the clinic in the treatment of nervous system diseases as compared to the therapeutic potential of MSCs. Moreover, MSC-EVs can avoid the risk of genetic changes associated with stem cell transplantation for the treatment of nerve disorders [264,265]. Remarkably, MSC-EVs can be modified to carry specific proteins or genes that promote cellular function and tissue repair.…”
Section: Extracellular Vesicles (Exosomes)mentioning
confidence: 99%